Projects funded by the NCN
Characterization and improvement of anti-cancer properties of second generation antagonists of Mdm2 oncoprotein
2016/21/D/NZ7/00596
Keywords:
Mdm2 p53 drug resistance antagonist tumorigenesis apoptosis cell cycle arrest combined therapy
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ1_1: Molecular biology
- NZ3_3: Apoptosis
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Wydział Chemii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: SONATA 11 - announced on 2016-03-15
Amount awarded: 688 320 PLN
Project start date (Y-m-d): 2017-02-06
Project end date (Y-m-d): 2020-02-05
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.